Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Hanf

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
American Journal of Obstetrics and Gynecology|November 18, 2004
Vulvitis granulomatosa and unilateral hypertrophy of the vulva related to Crohn's disease: a case reportAndreas R Günthert, Bernd Hinney, Kirsten Nesselhut, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 18, 2005
Effects of single non-ortho, mono-ortho, and di-ortho chlorinated biphenyls on human sperm functions in vitroSybille Pflieger-Bruss, Sandra Hagemann, Wolfgang Körner, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|July 23, 2020
[Is the Quality Guideline of Care Delivery of Preterm and Mature Infants (QFR-RL) of the Federal Joint Committee (G-BA) a Quality Risk? - An Analysis of the Fulfillment Rate and the Consequences for Care Delivery to Other IC Patients and Imminent Premature Infants at a Regional Network of Perinatal Centers]Markus Kleeberg, Matthias Beckmann, Christoph Fusch, et al.
Onkologie|July 8, 2011
Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patientsMatthias W Beckmann, Cosima Brucker, Volker Hanf, et al.
BMC Cancer|April 19, 2011
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×DocetaxelEva J Kantelhardt, Martina Vetter, Marcus Schmidt, et al.
Breast Cancer Research and Treatment|October 24, 2022
PIK3CA-mutations in breast cancerKristin Reinhardt, Kathrin Stückrath, Carolin Hartung, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer PatientsKathleen Schüler, Daniel Bethmann, Sandy Kaufhold, et al.
Breast Cancer Research and Treatment|December 8, 2025
Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancerVanessa Wieder, Julia Engel, Kathleen Eichstädt, et al.
Breast Cancer Research : BCR|October 13, 2017
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factorsStephan Bernhardt, Michaela Bayerlová, Martina Vetter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 17, 2020
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trialAnnette Hasenburg, Jalid Sehouli, Bjoern Lampe, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
American Journal of Obstetrics and Gynecology|November 18, 2004
Vulvitis granulomatosa and unilateral hypertrophy of the vulva related to Crohn's disease: a case reportAndreas R Günthert, Bernd Hinney, Kirsten Nesselhut, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 18, 2005
Effects of single non-ortho, mono-ortho, and di-ortho chlorinated biphenyls on human sperm functions in vitroSybille Pflieger-Bruss, Sandra Hagemann, Wolfgang Körner, et al.
Zeitschrift Fur Geburtshilfe Und Neonatologie|July 23, 2020
[Is the Quality Guideline of Care Delivery of Preterm and Mature Infants (QFR-RL) of the Federal Joint Committee (G-BA) a Quality Risk? - An Analysis of the Fulfillment Rate and the Consequences for Care Delivery to Other IC Patients and Imminent Premature Infants at a Regional Network of Perinatal Centers]Markus Kleeberg, Matthias Beckmann, Christoph Fusch, et al.
Onkologie|July 8, 2011
Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patientsMatthias W Beckmann, Cosima Brucker, Volker Hanf, et al.
BMC Cancer|April 19, 2011
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×DocetaxelEva J Kantelhardt, Martina Vetter, Marcus Schmidt, et al.
Breast Cancer Research and Treatment|October 24, 2022
PIK3CA-mutations in breast cancerKristin Reinhardt, Kathrin Stückrath, Carolin Hartung, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Prognostic Value of Tumour-Infiltrating Lymphocytes in an Unselected Cohort of Breast Cancer PatientsKathleen Schüler, Daniel Bethmann, Sandy Kaufhold, et al.
Breast Cancer Research and Treatment|December 8, 2025
Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancerVanessa Wieder, Julia Engel, Kathleen Eichstädt, et al.
Breast Cancer Research : BCR|October 13, 2017
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factorsStephan Bernhardt, Michaela Bayerlová, Martina Vetter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 17, 2020
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trialAnnette Hasenburg, Jalid Sehouli, Bjoern Lampe, et al.
Pageof 5